The effect of physostigmine and neostigmine on the concentration of glycogen in diaphragm and triceps muscle of the rat.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003964:Diaphragm / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006003:Glycogen / Q000378:metabolism*; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D009388:Neostigmine / Q000494:pharmacology*; D010830:Physostigmine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D013464:Sulfuric Acids / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D012459:Salicylates; D013464:Sulfuric Acids; D009388:Neostigmine; D001285:Atropine; D006003:Glycogen; D010830:Physostigmine; D011433:Propranolol